循環器内科 Twitter アカウントlanguage English

英文原著論文　Original Papers in English


緑色のタイトル部分をクリックすると、論文PDFが表示されます。

【 2025 年 】（IF: 2023 年）

  1. Yamada K, Satoh T, Yaoita N, Chiba N, Yamada Y, Komaru K, Onuma S, Godo S, Yamamoto S, Sato H, Nakata T, Nochioka K, Oishi H, Miyata S, Okada Y, Yasuda S. CTRP7 as a Molecular Biomarker Associating with Responsiveness to Pulmonary Vasodilators: Insights from Human and Animal Studies in Pulmonary Arterial Hypertension.Cardiovasc Res. 2025. (in press)

  2. Namiuchi S, Nochioka K, Ushigome R, Sunamura S, Tanita A, Ogata T, Noda K, Takii T, Shimokawa H, Yasuda S, the CHART-2 Investigators. Systemic inflammation-based Glasgow prognostic score as a prognostic indicator in chronic heart failure. Int J Cardiol Heart & Vascul. (in press) (IF=2.5)

  3. Sakata Y, Nochioka K, Yasuda S, Ishida K, Shiroto T, Takahashi J, Kasahara S, Abe R, Yamanaka S, Fujihashi T, Hayashi H, Kato S, Horii K, Teramoto K, Tomita T, M.D., Miyata S, Sugimura K, Waga, Nagasaki M, Shimokawa H. Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: an emerging entity of heart failure. Eur J Heart Fail. (in press) (IF=16.9)

  4. Arai M, Nakashima T, Noguchi T, Hifumi T, Inoue A, Sakamoto T, Kuroda Y, Tahara Y. Association Between Cannula Size of Extracorporeal Membrane Oxygenation and Prognosis in Patients With Out-of-Hospital Cardiac Arrest - A Secondary Analysis of the SAVE-J Ⅱ Study - Circ J. DOI: 10.1253/circj.cj-24-0442 (IF=3.1)

【 2024 年 】（IF: 2023 年）

  1. Satoh T, Yaoita N, Higuchi S, Nochioka K, Yamamoto S, Sato H, Tatebe S, Yamada K, Yamada Y, Komaru K, Chiba N, Sarashina Y, Mori R, Nakada M, Hayashi H, Suzuki H, Takahama H, Ota H, Yasuda S. Impact of Sodium-Glucose Co-Transporter-2 Inhibitors on Exercise-Induced Pulmonary Hypertension. Pulm Circ.2024 Dec 15;14(4): e70026. doi: 10.1002/pul2.70026. eCollection 2024 Oct

  2. Satoh T, Yaoita N, Higuchi S, Nochioka K, Yamamoto S, Sato H, Yamada K, Yamada Y, Komaru K, Chiba N, Nakada M, Miyata S, Ota H, Takase K, Yasuda S. Improving Balloon Pulmonary Angioplasty Through Target Endpoint Optimization With Pressure Catheter and Angiographic Lung Perfusion.JACC Cardiovasc Interv.2024 Oct 28;17(20):2394-2407. doi: 10.1016/j.jcin.2024.08.045.

  3. Yamanaka S, Suzuki H, Yasuda S.　Fatal coronary embolism in infective endocarditis: a case of sudden circulatory collapse. European Heart Journal (in press) (IF=37.6)

  4. Hao K, Takahashi J, Sato K, Fukui K, Shindo T, Oyama K, Nishimiya K, Godo S, MD, Shiroto T, Shimokawa H, Yasuda S. Clinical characteristics and outcome of patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) in Japan: Insights from the Miyagi AMI Registry Study. J Am Heart Assoc. (in press) (IF=6.1)

  5. Ishii T, Kawaguchi Y, Ishikawa O, Takemori H, Takasawa N, Kobayashi H, Takahashi Y, Yasuoka H, Kodera K, Takai O, Nakaya I, Fujii H, Kamogawa Y, Shirota Y, Shirai T, Fujita Y, Saito S, Chiu SH, Yamaguchi T, Shimokawa H, Harigae H. Effectiveness and safety of low-energy shock wave therapy for digital ulcers associated with systemic sclerosis: a phase 3 pivotal clinical trial. Modern Rheumatology. (in press) (IF=2.2)

  6. Onuma S, Takahashi J, Shiroto T, Godo S, Hao K, Honda S, Nishihira K, Kojima S, Takegami M, Sakata Y, Itoh T, Watanabe T, Watanabe M, Takayama M, Sumiyoshi T, Kimura K, Yasuda S; JAMIR Investigators　Characteristics and In-Hospital Outcomes of Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries - Insights From the Real-World JAMIR Database　Circ J. 2024 Oct 9. Online ahead of print. DOI:10.1253/circj.CJ-24-0422. (IF=3.1)

  7. Hayashi H, Nochioka K, Nakano M, Shiroto T, Hasebe Y, Noda T, Miyata S, Shimokawa H, Yasuda S. Sex differences in sudden cardiac death during the long-term follow-up in patients with chronic heart failure -A report from the CHART-2 Study- Circ J. (in press) (IF=3.1)

  8. Yoshiki Y, Ozaki Y, Abe M, Ismail TF, Takahashi H, Akao M, Kawai H, Muramatsu T, Harada M, Ohta M, Hashimoto Y, Shiki Y, Miyajima K, Takatsu H, Niwa Y, Kawashima N, Ozaki R, Tsuboi N, Iimuro S, Iwata H, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Ogawa H, Daida H, Shimokawa H, Kitamura H, Izawa H, Kimura T, Nagai R, REAL-CAD investigators. Influence of worsening renal function and baseline chronic kidney disease on clinical outcomes in patients with chronic coronary syndromes; Insights from the REAL-CAD Study. J Am Heart Assoc. (in press) (IF=5.0)

  9. Takeuchi K, Suzuki H, Takanami T, Ota H, Tanaka Y, Fujishima F, Watanabe H, Susukita K, Inoue T, Arai M, Hayashi H, Nochioka K, Takahama H, Suzuki T, Takase K, Yasuda S. Reduced 18F-FDG uptake in the basal interventricular septum as a predictor of fatal ventricular arrhythmic events in patients with cardiac sarcoidosis. Int J Cardiol 2024 (in press)(IF=3.2)

  10. Nochioka K, Yasuda S, Shiroto T, Yamamoto S, Sato H, Hasebe Y, Godo S, Nakano M, Shindo T, Nishimiya K, Hao K, Takahashi J, Ido K, Kakuta Y, Shimizu H, Shimokawa H, Nakayama M.　The Outcomes of Electronic Personal Health Records in Patients with Heart Failure or Coronary Artery Disease. ESC Heart Failure (in press) (IF=3.2)

  11. Sato H, Noda T, Ito T, Yamamoto N, Chiba T, Hasebe Y, Nakano M, Ueda N, Kamakura T, Ishibashi K, Kusano K, Yasuda S.　Optimizing Patient Selection for Cardiac Resynchronization Therapy with or without Defibrillator in a Multicenter Study of Japanese Patients: Assessment of the MADIT-ICD Benefit Score. Circulation Journal (in press) (IF=3.1)

  12. Yamamoto N, Nakano M, Nochioka K, Yasuda M, Kunikata H, Nakazawa T, Yasuda S. Ocular blood flow dynamics following sinus rhythm restoration through catheter ablation: laser speckle flowgraphy in patients with persistent atrial fibrillation European Heart Journal - Imaging Methods and Practice (2024) 2, qyae071 DOI: 10.1093/ehjimp/qyae071

  13. Ito T, Noda T, Nochioka K, Shiroto T, Yamamoto N, Sato H, Chiba T, Hasebe Y, Nakano M, Takahama H, Takahashi J, Miyata S, Shimokawa H, Yasuda S. OClinical impact of atrial fibrillation progression in patients with heart failure with preserved ejection fraction: A report from the CHART-2 study. Europace. 2024 Aug 30;26(9):euae218. (IF=7.9)

  14. Hibi K, Gohbara M, Uemura K, Iwahashi N, Okada K, Iwata H, Fukumoto Y, Hiro T, Ozaki Y, Iimuro S, Sakuma I, Hokimoto S, Miyauchi K, Matsuyama Y, Nakagawa Y, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Matsuzaki M, Kimura K, Nagai R. Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular disease. J Clin Lipidol. 2024 Jul 17:S1933-2874(24)00212-5. (IF=3.6)

  15. Kaikita K, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Shimizu W, Ikeda T, Kamouchi M, Fukuda K, Origasa H, Shimokawa H. Antiplatelets for cardiovascular disease in non-valvular AF with rivaroxaban: EXPAND subanalysis. J Atheroscler Throm. 2024 Sep 28. doi: 10.5551/jat.64681. Online ahead of print. (IF=3.0)

  16. Takahama H, Kitai T, Nakagawa S, Takegami M, Hamatani Y, Nakamoto K, Ohtani T, Yamamoto J, Shintani Y, Anchi Y, Azechi M, Kawano Y, Takada Y, Yumino D, Seo Y, Sakata Y, Akao M, Yasuda S, Nishimura K, Izumi C. Rationale and design of a multicenter trial on exploratory analysis of the effects of advance care planning guided by the prediction program of heart failure prognosis on quality of life in patients with heart failure: ACQUAINT-trial Circ Rep. (in press)

  17. Takiguchi H, Miura M, Shirai S, Soga Y, Hanyu M, Sakaguchi G, Soga Y, Arai Y, Watanabe S, Kimura T, Takahama H, Yasuda S, Nakayoshi T, Fukumoto Y, Yaoita N, Shimokawa H, Sakatsume K, Saiki Y, Kaikita K, Tsujita K, Tamura T, Doman T, Yamashita M, Suzuki M, Eura Y, Kokame K, Hayakawa M, Matsumoto M, Okubo N, Sugawara S, Fujimaki S, Kawate Y, Ando K, Horiuchi H. Mitral regurgitation is associated with similar loss of von Willebrand factor large1 multimers, but less anemia as compared to aortic stenosis. Res Prac Thromb Haemost. 2024 May 3;8(4):102431. (IF=3.4)

  18. Teramoto K, Nochioka K, Sakata Y, Kato ET, Nishimura K, Shimokawa H, Yasuda S, the SUPPORT Trial Investigators. Growth differentiation factor-15 and metabolic features in chronic heart failure: Insights from the SUPPORT Trial -GDF15 across the BMI spectrum- Int J Cardiol. 2024 Jul 15;407:132093. (IF=3.2)

  19. Suzuki H, Inoue T, Terui Y, Takeuchi K, Susukita K, Arai M, Sato H, Satoh T, Yamamoto S, Yaoita N, Tatebe S, Hayashi H, Nochioka K, Takahama H, Yasuda S. Evaluating hemodynamic changes: vericiguat in patients with heart failure with reduced ejection fraction. ESC Heart Failure (in press) (IF=3.2)

  20. Fukumoto Y, Tada T, Suzuki H, Nishimoto Y, Moriuchi K, Arikawa T, Adachi H, Momomura S, Seino Y, Yasumura Y, Yokoyama H, Hiasa G, Hidaka T, Nohara S, Okayama H, Tsutsui H, Kasai T, Takata Y, Enomoto M, Saigusa Y, Yamamoto K, Kinugawa K, Kihara Y. Chronic effects of adaptive servo-ventilation therapy on mortality and the urgent rehospitalization rate in patients experiencing recurrent admissions for HF: a multicenter, prospective, observational study (SAVIOR-L). Circulation Journal (in press) (IF=3.1)

  21. Shindo T, Eguchi K, Monma Y, Kanai H, Yasuda S, Shimokawa H. Optimal treatment conditions of the low-intensity pulsed ultrasound therapy for the treatment of Alzheimer’s disease -Applications from mice to humans- J Med Ultrasonics. 51:419-427,2024. (IF=1.9)

  22. Yamanaka S, Nochioka K, Hayashi H, Shiroto T, Takahashi J, Miyata S, Yasuda S, Shimokawa H. Age-stratified profiles and outcomes of patients with heart failure with preserved ejection fraction. ESC Heart Failure 2024 Aug;11(4):2223-2233. (IF=3.2)

  23. Nakano M, Yasuda S, Hasebe Y, Nochioka K, Fukuda K, Takahashi J, Shimokawa H. Inhibitory effect of rivaroxaban on protease-activated receptor-2 in circulating neutrophils among patients with atrial fibrillation. Int J Cardiol Heart & Vasculature. 2024 Mar 20;52:101387. (IF=3.2)

  24. Yamamoto N, Noda T, Nakano N, Ito T, Sato H, Hayashi H, Chiba T, Hasebe Y, Ueda N, Kamakura T, Ishibashi K, Miyata S, Kusano K, Yasuda S. Clinical Utility of QRS Duration Normalized to Left Ventricular Volume for Predicting Cardiac Resynchronization Therapy Efficacy in Patients with "Mid-Range" QRS Duration Heart Rhythm 2024 Feb 15:S1547-5271(24)00190-5.(Online ahead of print) DOI: 10.1016/j.hrthm.2024.02.019. (IF=5.6)

  25. Teramoto K, Nochioka K, Sakata Y, Nishimura K, Shimokawa H, Yasuda S, the SUPPORT Trial Investigators. Prognostic significance of growth differentiation factor-15 across age in chronic heart failure. ESC Heart Failure 2024 Jun;11(3):1666-1676. (IF=3.2)

  26. Ouchi D, Mori S, Arakawa M, Shindo T, Shimokawa H, Yasuda S, Kanai H. Optimizing irradiation conditions for low-intensity pulsed ultrasound to upregulate endothelial nitric oxide synthase. J Med Ultrasonics 51:39-48,2024. (IF=1.9)

  27. Fujihashi T, Nochioka K, Yasuda S, Sakata Y, Hayashi H, Shiroto T, Takahashi J, Miyata S, Shimokawa H. Underuse of heart failure medications and poor long-term prognosis in chronic heart failure patients with polypharmacy -A report from the CHART-2 Study- Int J Cardiol Heart & Vasculature. 2024 Jan 23;50:101345. (IF=3.2)